Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT00720785
Title Natural Killer Cells and Bortezomib to Treat Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Heart, Lung, and Blood Institute (NHLBI)
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.